Showing results (171-180 of 245) with videos related to

Sort By:
Pageof 25
European Journal of Cancer (Oxford, England : 1990)|September 26, 2020
Oligometastatic colorectal cancer: prognosis, role of locoregional treatments and impact of first-line chemotherapy-a pooled analysis of TRIBE and TRIBE2 studies by Gruppo Oncologico del Nord OvestRoberto Moretto, Daniele Rossini, Gemma Zucchelli, et al.
The Oncologist|October 9, 2015
Single-Agent Panitumumab in Frail Elderly Patients With Advanced RAS and BRAF Wild-Type Colorectal Cancer: Challenging Drug Label to Light Up New HopeFilippo Pietrantonio, Chiara Cremolini, Giuseppe Aprile, et al.
European Journal of Cancer (Oxford, England : 1990)|December 18, 2016
Efficacy of FOLFOXIRI plus bevacizumab in liver-limited metastatic colorectal cancer: A pooled analysis of clinical studies by Gruppo Oncologico del Nord OvestChiara Cremolini, Mariaelena Casagrande, Fotios Loupakis, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 29, 2016
Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real worldValentina Fanotto, Stefano Cordio, Giulia Pasquini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2025
Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 TrialHarriet Johansson, Debora Macis, Martino Oliva, et al.
Journal of Chemotherapy (Florence, Italy)|July 27, 2021
Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysisRoberto Filippi, Francesco Leone, Lorenzo Fornaro, et al.
Cancers|July 30, 2020
TP53 Mutation Analysis in Gastric Cancer and Clinical Outcomes of Patients with Metastatic Disease Treated with Ramucirumab/Paclitaxel or Standard ChemotherapyFrancesco Graziano, Nicholas W Fischer, Irene Bagaloni, et al.
British Journal of Cancer|March 14, 2018
Differential histopathologic parameters in colorectal cancer liver metastases resected after triplets plus bevacizumab or cetuximab: a pooled analysis of five prospective trialsChiara Cremolini, Massimo Milione, Federica Marmorino, et al.
European Journal of Cancer (Oxford, England : 1990)|February 9, 2019
Phase II randomised study of maintenance treatment with bevacizumab or bevacizumab plus metronomic chemotherapy after first-line induction with FOLFOXIRI plus Bevacizumab for metastatic colorectal cancer patients: the MOMA trialChiara Cremolini, Federica Marmorino, Francesca Bergamo, et al.
JAMA Oncology|November 27, 2018
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan: A Phase 2 Single-Arm Clinical TrialChiara Cremolini, Daniele Rossini, Emanuela Dell'Aquila, et al.
Pageof 25